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Abstract
Background: Mercury is a prominent environmental contaminant that causes detrimental effects to human health. 
Although the liver has been known to be a main target organ, there is limited information on in vivo molecular 
mechanism of mercury-induced toxicity in the liver. By using transcriptome analysis, phenotypic anchoring and 
validation of targeted gene expression in zebrafish, mercury-induced hepatotoxicity was investigated and a number of 
perturbed cellular processes were identified and compared with those captured in the in vitro human cell line studies.
Results: Hepato-transcriptome analysis of mercury-exposed zebrafish revealed that the earliest deregulated genes 
were associated with electron transport chain, mitochondrial fatty acid beta-oxidation, nuclear receptor signaling and 
apoptotic pathway, followed by complement system and proteasome pathway, and thereafter DNA damage, hypoxia, 
Wnt signaling, fatty acid synthesis, gluconeogenesis, cell cycle and motility. Comparative meta-analysis of microarray 
data between zebrafish liver and human HepG2 cells exposed to mercury identified some common toxicological 
effects of mercury-induced hepatotoxicity in both models. Histological analyses of liver from mercury-exposed fish 
revealed morphological changes of liver parenchyma, decreased nucleated cell count, increased lipid vesicles, 
glycogen and apoptotic bodies, thus providing phenotypic evidence for anchoring of the transcriptome analysis. 
Validation of targeted gene expression confirmed deregulated gene-pathways from enrichment analysis. Some of 
these genes responding to low concentrations of mercury may serve as toxicogenomic-based markers for detection 
and health risk assessment of environmental mercury contaminations.
Conclusion: Mercury-induced hepatotoxicity was triggered by oxidative stresses, intrinsic apoptotic pathway, 
deregulation of nuclear receptor and kinase activities including Gsk3 that deregulates Wnt signaling pathway, 
gluconeogenesis, and adipogenesis, leading to mitochondrial dysfunction, endocrine disruption and metabolic 
disorders. This study provides important mechanistic insights into mercury-induced liver toxicity in a whole-animal 
physiology context, which will help in understanding the syndromes caused by mercury poisoning. The molecular 
conservation of mercury-induced hepatotoxicity between zebrafish and human cell line reveals the feasibility of using 
zebrafish to model molecular toxicity in human for toxicant risk assessments.
Background
Mercury is a highly hazardous pollutant with an estimated
global natural mercury emission of 1,800-5,800 tons per
annum [1] and global anthropogenic mercury emission to
the atmosphere was estimated to be 2,190 tons in 2000 [2].
Since mercury is ubiquitous in the environment, it is nearly
impossible for most humans and animals to avoid exposure
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to some forms of mercury, be it elementary, organic or inor-
ganic. Mercury, through biotransformation and bioaccumu-
lation, has found its way through the food chain to humans.
Anthropogenic activities and industrialization are also
sources of mercury pollution that had resulted in several
catastrophe of mercury poisoning in Japan [3], the Amazon
basin [4] and Iraq [5], and recently many high-risk sites
have been identified in Asia [1]. Moreover, mercury pollu-
tion and poisoning have imposed a huge economic cost on
environmental remediation and public health [6,7].
All forms of mercury cause toxic effects in a number of
tissues and organs depending on the chemical form of mer-
cury as well as the level, duration and the route of exposure
[8-11]. Exposure to mercury compounds typically occurs
by inhalation or ingestion. Ingested mercury is absorbed in
the gastrointestinal tract and it is distributed to all tissues in
about 30 h while inhaled through mercury vapor accumu-
lates in red blood cells and is carried to all tissues in the
body in less than 24 h [11]. Mercury undergoes extensive
biliary-hepatic cycling [12]. It is secreted into bile and
partly reabsorbed into the portal circulation and thereby
returned to the liver. The high mobility of mercury in the
body is attributed to the formation of water-soluble mercury
complexes that are mainly, if not exclusively, attached to
the sulfur atom of thiol groups such as glutathione [11]. The
glutathione moiety is degraded in the bile duct and gall
bladder to a dipeptide and finally to an L-cysteine mercury
complex before entering the circulatory system [12]. It is in
the form of the L-cysteine complex that mercury enters the
endothelial cells of the blood-brain and placental barriers.
Mercury can gradually accumulate in the central nervous
system and kidney, thus causing damage to these organs.
Hence, there have been several molecular mechanistic stud-
ies on neurological [13] and renal [14] toxicities induced by
mercury. However, despite of the fact that the extensive bil-
iary-hepatic cycling of mercury [12] and of some evidence
suggesting that liver plays a role in renal tubular uptake of
mercury [14], little is known with regard to the mechanism
of mercury-induced hepatotoxicity. Based on the role of
liver in mercury biotransforming and cycling, as well as its
central roles in the control and synthesis of critical blood
constituents that affect whole body physiology, we hypoth-
esized that mercury exposure can cause liver injury that
may lead to other syndromes. In view of the prevalence of
mercury exposure in humans, understanding of the mecha-
nism of mercury-induced hepatotoxicity is therefore impor-
tant for elucidating its impact on liver health.
The advent of omics technologies such as genomics and
transcriptomics has enabled the simultaneous assessment of
expression profiles of thousands of genes that respond to a
toxic compound within a particular cell type, tissue, or an
organism [15]. The zebrafish is an increasingly popular
model not only for vertebrate development [16] but also for
understanding human diseases [17] and toxicology [18].
Many physiological and molecular similarities in xenobi-
otic metabolism and adaptive response to toxicant insults
have been found between zebrafish and mammals, making
the zebrafish an ideal toxicology model in toxicology
[19,20]. Although zebrafish has become popular as an in
vivo system to model human diseases and toxicities, toxi-
cogenomic researches using zebrafish seem not to have
been extensively conducted. We and others have shown that
zebrafish responded biologically to chemicals, such as
small molecules, drugs and environmental toxicants, in a
similar manner as mammals [21-24]. The availability of
zebrafish in large numbers, its small size and easy hus-
bandry makes zebrafish a cost-effective model when com-
pared to the rodent model for toxicological studies. In
addition, the amenability of the zebrafish system to various
molecular techniques and the vast genomic resources,
including the near-completed zebrafish genome project and
available zebrafish microarrays, make it a highly versatile
system for toxicogenomic studies. Moreover, fish have long
been used as sentinels for biomonitoring of aquatic environ-
mental pollutants and are good indicators of mercury pollu-
tion [19,20].
To our knowledge, there is no research report to elucidate
the in vivo hepatotoxicity mechanism induced by mercury
as well as its induced syndromes. Recent work by Gonzalez
et al had indicated that the liver of the zebrafish is one of
the main organs of mercury accumulation during the first 7
days of exposure to methylmercury [25]. In this study, we
aimed to investigate the in vivo mechanism of mercury-
induced hepatotoxicity using the zebrafish as a model and
compared it with other published data. To date, most mech-
anistic studies of mercury-induced toxicity in human/mam-
mals have been performed either in vitro or in vivo using
non-liver tissue. However, mechanistic insight obtained
from the in vitro systems can be quite different from those
obtained from the in vivo environment because of the lack
of coordination of biological processes in whole organism.
As the liver is the main organ that performs detoxification
processes as well as regulation of metabolic pathways, it is
important to understand toxicity effects and malfunctions
that may implicate metabolic disorders induced by some
toxicants in liver in vivo.
Here, using the DNA microarray technology, we captured
the kinetics of hepatic transcriptome changes in zebrafish
upon mercury exposure in order to generate a global tran-
scriptome view of mercury-induced hepatotoxicity. Using
gene set enrichment analysis (GSEA) and knowledge-based
data mining, we compared our findings with those reported
in human liver cell line and/or in mammalian model. We
performed phenotype anchoring by linking histological
analyses to the transcriptome data and subsequently per-
formed gene expression validation using real-time PCR on
a separate set of samples from seperate mercury exposure
experiments. Taken together, we proposed a plausible inUng et al. BMC Genomics 2010, 11:212
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vivo mechanistic model of mercury-induced hepatotoxicity
that could lead to syndromes related to mitochondrial dys-
function, endocrine disruption and metabolic disorders.
Results and discussion
Characterization of mercury-induced hepatotoxicity 
responses in zebrafish from transcriptome analysis
Preliminary acute toxicity test was first performed to deter-
mine the appropriate concentrations of mercuric chloride
(HgCl2) for DNA microarray experiments. Fishes were
treated with different concentrations of HgCl2 ranging from
100 to 600 μg/L for 7 days. Acute toxicity and motility test
for HgCl2 exposure treatment revealed that 600 μg/L HgCl2
caused all the fish to die within 2 days, while treatment at
concentrations of 200 μg/L produced 90% of survival rate
up to 7 days (See Additional file 1). All surviving fish
treated with 200 μg/L displayed normal swimming behav-
ior without obvious adverse effect. Therefore, 200 μg/L of
HgCl2 was chosen for the subsequent DNA microarray
experiments as the concentration was sufficient to induce
acute toxicity with minimal mortality.
Bioaccumulation of HgCl2 was not determined in the
present study. In a similar study recently published [26],
0.15 mg/L HgCl2 was used for exposure in another tropical
freshwater fish, Brycon amazonicus, and 10.46 mg Hg per
kg liver from treated fish was detected in fish liver at 96 h
and thus a bioaccumulation factor of about 100 in the liver
was estimated.
Based on the transcriptome data, genes that were signifi-
cantly regulated by mercury were identified at different
time points (8 h, 24 h, 48 h and 96 h) with p-value < 0.05
and mapped to human homologous genes (See Additional
file 2). Compared to 8 h time point, the number of genes
significantly deregulated (both up- and down-regulated) at
24 h increased dramatically and a further increase was
observed at 96 h time point. The increasing numbers of dif-
ferentially expressed genes may serves as a rough indica-
tion that more biological processes were deregulated with
the increase of duration of mercury exposure up to 96 h.
Gene set enrichment analyses (GSEA), which employs a
statistical algorithm to compare the entire ranked list of
genes through transcriptome profiles with defined knowl-
edge-based gene sets obtained from established biological
knowledge [27, see Methods], was used to determine bio-
logical pathways perturbed by HgCl2. Biological pathways
that are statistically enriched (nominal p-value [NP] <0.1 or
false discovery rate [FDR] <0.3) from whole transcriptome
analyses at the four time points (8 h, 24 h, 48 h and 96 h) of
HgCl2 treatment using GSEA are shown in Table 1. The
activities of the enriched pathways are indicated in normal-
ized enrichment scores (NES) as described in the Methods
section. Positive and negative NES values indicate up- and
down-regulation of genes associated with pathways, respec-
tively. In addition, we also explored canonical pathways
that are enriched using the Ingenuity Pathway Analysis
(IPA) System http://www.ingenuity.com/. We considered
early (8 and 24 h) and late (48 and 96 h) stages in this anal-
ysis and the top 10 enriched canonical pathways were com-
pared with results from GSEA (data not shown). Results
from both GSEA and IPA suggest that pathways associated
with protein degradation, stress, acute phase responses,
mitochondrial dysfunction, and cell damage are enriched
(data not shown).
The transcriptome analysis using GSEA revealed that
genes associated with electron transport chain, mitochon-
drial fatty acid beta-oxidation, nuclear receptor signaling
and apoptotic pathway were down-regulated as early as 8 h
of HgCl2 exposure. This was followed by up-regulation of
genes associated with the complement system and protea-
some pathway, suggesting increased activity of these pro-
cesses at 24 h. Major processes that were affected
throughout the latter three time points of HgCl2 treatments
(24 h, 48 h and 96 h) were proteasome pathway, electron
transport chain, and mitochondrial fatty acid beta-oxidation
(Table 1). Interestingly, electron transport chain that was
initially down-regulated at 8 h were subsequently up-regu-
lated at 48 h and 96 h, implying an increased need of intrac-
ellular energy production presumably to compensate the
early down-regulation and to meet the energy requirement
of the adaptive response to HgCl2 exposure. At 96 h of
HgCl2 exposure, more biological pathways were signifi-
cantly affected such as up-regulation of actin pathway, fatty
acid synthesis, DNA damage signaling pathway, classical
complement activation, intrinsic apoptotic pathway, cell
motility, hypoxia-induced factor pathway, and gluconeo-
genesis, as well as down-regulation of cell cycle, non-sub-
strate Gsk3 interacting proteins, and Wnt signaling
pathway.
Taken together, the transcriptome analysis revealed that
early targets of mercury-induced hepatotoxicity involved
mitochondrial processes (electron transport chain and fatty
acid beta-oxidation), apoptotic pathway and nuclear recep-
tor signaling. The following up-regulation of complement
system and proteasome pathway suggest activation of acute
phase response and increased degradation of damaged pro-
teins within 24 h of HgCl2 exposure. By 96 h, several criti-
cal processes associated with cellular maintenance, stress,
survival and metabolism were clearly deregulated in the
liver. Earlier work by Gonzalez et al [25] using the
zebrafish to elucidate effects of methylmercury on gene
expression in liver, skeletal muscle, and brain indicated
genes involved in mitochondrial metabolism, detoxification
process, DNA repair and apoptosis were generally deregu-
lated. Hence, there are similar observed toxicity effects
between inorganic mercury and organic mercury such asUng et al. BMC Genomics 2010, 11:212
http://www.biomedcentral.com/1471-2164/11/212
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methylmercury. Thus, it is important to further understand
the mechanism of their in vivo toxicity in future works.
Comparative analysis revealed some common mercury-
induced processes in both zebrafish liver and human liver 
cell line
In order to determine molecular conservation of mercury-
induced hepatotoxicity, we compared pathways that were
induced or suppressed by HgCl2 between zebrafish and
human cell line using GSEA. Transcriptome data of liver
cell line (HepG2) exposed to 20 μM of HgCl2 for 6 h were
obtained from the Gene Expression Omnibus (GEO Acces-
sion GSE6907, http://www.ncbi.nlm.nih.gov/geo/) and used
for comparative study with our zebrafish transcriptome
data. Deregulated processes with FDR< 0.3 or NP < 0.1
were selected. Comparative GSEA revealed that DNA
damage signaling and proteasome pathway were both up-
regulated in zebrafish liver and HepG2 cells. Likewise,
nuclear receptor signaling pathway, mitochondrial fatty
acid beta-oxidation and electron transport chain (8 h in
zebrafish) were down-regulated by HgCl2 in both zebrafish
liver and HepG2 cells, indicating similar mode-of-action of
Table 1: Gene Set Enrichment Analysis (GSEA) of liver transcriptome of HgCl2-treated zebrafish.
Up-regulated NES Down-regulated NES
8 h Electron transport chain -2.1201 (15)
Mitochondrial fatty acid beta-
oxidation
-1.4134 (10)
Nuclear receptor signaling pathway -1.484 (7)
Extrinsic apoptotic pathway -1.5717 (4)
24 h Proteasome pathway 1.7531 (7) Mitochondrial fatty acid beta-
oxidation
-1.7489 (10)
Complement activation 
(classical)
1.6751 (2)
48 h Proteasome pathway 2.0369 (8) Mitochondrial fatty acid beta-
oxidation
-1.5011 (6)
Electron transport chain 1.6143 (15) Nuclear receptor signaling pathway -1.689 (8)
96 h Proteasome pathway 1.9855 (5) Non-substrate GSK3 interacting 
proteins
-1.533 (5)
Complement activation 
(classical)
1.435 (2) Cell cycle -1.3784 (12)
DNA damage signaling pathway 1.4009 (14) Wnt signaling pathway -1.337 (8)
Actin pathway 1.7501 (3)
Fatty acid synthesis 1.5715 (4)
Intrinsic apoptotic pathway 1.401 (4)
Hypoxia-induced factor pathway 1.3243 (5)
Cell motility 1.2936 (5)
Gluconeogenesis 1.0784 (7)
Electron transport chain 1.6832 (18)
Biological pathways that are statistically enriched with false discovery rate (FDR) < 0.3 or nominal p-value (NP) < 0.1 are shown. Values of 
normalized enrichment score (NES) indicate the activities of enriched pathways with positive and negative NES shows up- and down-
regulation, respectively. Number of leading edge genes for each pathway is given in bracket besides the NES values.Ung et al. BMC Genomics 2010, 11:212
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HgCl2 in these two models at certain levels (Tables 1 and
2).
However, unlike zebrafish, HepG2 cells showed up-regu-
lation of cell cycle, pyrimidine metabolism and DNA repair
owing to the proliferative state of HepG2 cells (Table 2).
This may indicate differential toxicity responses between
proliferative cell cultures and highly differentiated in vivo
models. More importantly, being an in vivo model, the
zebrafish liver data has an advantage to capture deregulated
biological processes that involves interactions of various
cell types and whole-organism physiological metabolic pro-
cesses such as fatty acid synthesis, gluconeogenesis, and
other processes involving non-substrate Gsk3 interacting
proteins and complement activation. Thus, using an in vivo
model such as zebrafish may help researchers to character-
ize pathways that are perturbed by toxicants under in vivo
environments.
HgCl2 affected liver cell morphology and cell adhesion
In order to further elucidate the mechanism of mercury-
induced hepatotoxicity, we performed phenotypic anchor-
ing [28,29] by linking histological evidence to the mercury-
induced transcriptome changes. This was further validated
by real-time PCR for targeted genes associated with mer-
cury-induced phenotype/pathology and transcriptome
changes in the liver. In these experiments, we treated a new
batch of zebrafish with different concentrations of HgCl2,
from environmental-relevant (10 and 50 μg/L) to sub-lethal
concentration (200 μg/L). Real-time PCR validation of tar-
geted genes were performed on liver samples from
zebrafish treated with 10, 50 and 200 μg/L for 24 h while
phenotype anchoring were performed using liver from
zebrafish treated with 50 and/or 200 μg/L for 96 h.
Qualitative histological examinations for samples stained
with hematoxylin and eosin (H&E) had revealed that
hepatic parenchyma cells appeared to be less homogeneous
in HgCl2-treated fish than in control fish (Figure 1). At a
high magnification, it was observed that the liver paren-
chyma from HgCl2-treated fish appeared to be loose in cell
contact and the cells were dissociated and irregular in shape
(Figure 1b, 1c, 1e and 1f) while control fish liver is filled
with well-delineated polygonal cells (Figure 1a and 1d).
Immunohistochemical staining of E-cadherin, a trans-
membrane cell adhesion protein, was weaker and less dis-
tinct between the liver cells in HgCl2-treated fish than
control fish, suggesting that membrane integrity and cell
adhesion were affected (Figure 2a and 2b). Likewise,
immuno-staining of keratin-8 revealed a weaker staining of
the cytoskeletal protein in liver cells of mercury-treated fish
than those of control fish (Figure 2c and 2d), suggesting
altered cytoskeletal organization and assembly which can
affect cell morphology and motility. Thus, the histological
phenotypes such as changes in cell morphology, cell adhe-
sion and cytoskeletal proteins observed in the liver of
HgCl2-treated zebrafish corroborated with the deregulated
biological processes such as the actin pathway, Wnt signal-
ing pathway and cell motility as identified in the transcrip-
tome analysis.
HgCl2 decreased hepatocyte cell number via induction of 
apoptosis
Quantitative counting of nucleated hepatic cell counts
based on H&E stained sections revealed that HgCl2
decreased the number of hepatic parenchyma cells signifi-
cantly in a concentration-dependent manner (Figure 3a).
The number of hepatic parenchyma cell decreased approxi-
mately 20% and 50% in livers of fish treated with 50 and
200 μg/L HgCl2, respectively, when compared to livers of
control fish. Immunohistochemical-staining of DNA break-
age induced by apoptosis detected higher incidence of
apoptotic DNA fragments in livers of HgCl2-treated fish
than control fish (Figure 3b to 3c). Transcriptome analysis
supported this observation, as indicated by the fact that
intrinsic apoptotic pathway was induced at 96 h by HgCl2
(Table 1). In addition, it has been shown that HgCl2 induced
apoptosis in human leukemia cells via a mitochondrial-
dependent intrinsic apoptotic pathway [30]. Therefore, our
findings implicate that the decrease in liver cells is caused
by induction of apoptosis via the mitochondrial intrinsic
apoptotic pathway.
HgCl2 induced fatty liver condition
By oil red O staining, dosage-dependent lipid accumula-
tion, as indicated by the increased number and size of red-
stained lipid vesicles, was detected in the liver of HgCl2-
treated fish (Figure 4a to 4c). The histological phenotype
Table 2: Gene Set Enrichment Analysis (GSEA) of 
transcriptome of mercury-treated human HepG2 cells.
Enriched processes NES HepG2
Cell cycle 2.2425
Pyrimidine metabolism 2.049
DNA repair 1.6355
DNA damage signaling* 1.4957
Proteasome pathway* 1.5095
Electron transport chain* -1.4248
Nuclear receptor signaling 
pathway*
-1.5093
Mitochondrial fatty acid 
beta-oxidation*
-1.7171
Biological pathways that are statistically enriched with false 
discovery rate (FDR) < 0.3 or nominal p-value (NP) < 0.1 are 
considered. * indicate pathways that are common in zebrafish 
and HepG2 cell treated with HgCl2.Ung et al. BMC Genomics 2010, 11:212
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was thus consistent with the transcriptome analysis where
up-regulation of fatty acid synthesis and down-regulation of
mitochondrial fatty acid beta-oxidation were found in the
liver of HgCl2-treated zebrafish (Table 1). Accumulation of
lipids can lead to adipogenesis, steatostasis or non-alco-
holic fatty liver diseases. The transcription factors CCAAT/
enhancer-binding proteins (C/ebps) are known to modulate
gene expression leading to adipogenesis [31,32]. Hence, we
performed quantitative real-time PCR on β-c/ebp, δ-c/ebp,
apolipoprotein M (apom) and found that they were indeed
up-regulated by HgCl2 (Figure 4d, 4e, 4f) as suggested by
transcriptome data. As shown in Figure 4d and 4e, both β-c/
ebp and δ-c/ebp were induced by HgCl2 at concentrations as
low as 10 μg/L, suggesting that these transcription factors
were very sensitive to mercury-induced lipid accumulation
in the liver and are potential biomarkers for mercury expo-
sure as well as for fatty-liver condition.
HgCl2 induced glycogen accumulation in liver
By Periodic Acid-Schiff (PAS) staining, we observed
increasing glycogen content, as indicated by the increased
'pink staining', in livers of zebrafish treated with increasing
concentrations of HgCl2 (Figure 5a to 5c). The increase of
glycogen content in liver of mercury-treated zebrafish cor-
related with the up-regulation of gluconeogenesis based on
transcriptome data (Table 1). Real-time PCR confirmed that
gene expression for both glycogen phosphorylase (gp) and
glycogen synthase kinase 3 (gsk3) were up-regulated by
HgCl2 in a concentration-dependent manner (Figure 5d and
5e). In addition, a previous study [33] has shown significant
elevation of glycogen level in vas deferens of male rat
treated with HgCl2, suggesting that mercury may cause
metabolic disorders via increased level of glycogen.
Comparative analysis revealed similarity of mercury- and 
arsenic-induced processes in zebrafish liver
We have previously reported that arsenic exposure in adult
zebrafish caused decreased number of hepatic parenchyma
cells as well as altered cell adhesion and cytoskeleton [23].
Due to similarity of the toxicity effects between these two
compounds, we compared transcriptome profiles between
mercury and arsenic in the zebrafish liver using GSEA.
Similar statistical criteria were used to select enriched path-
ways induced by arsenic (See Additional file 3). Arsenic
induced proteasome pathway and intrinsic apoptotic path-
way as early as 8 h of arsenic exposure. Unlike mercury,
extrinsic apoptotic pathway is not enriched. Also, DNA
damage signaling pathway was significantly up-regulated at
96 h of arsenic treatment although positive NES values
were observed at an earlier time point. Like the case of mer-
cury, Wnt signaling was also significantly down-regulated
in Asenic-treated livers. However, unlike mercury, gluco-
neogenesis and fatty acid synthesis were down-regulated by
Figure 1 Hematoxylin and eosin (H&E) staining of liver sections from zebrafish treated with mercury. Adult zebrafish were treated with 0 (con-
trol, a and b), 50 mg/L (b and e) and 200 mg/L HgCl2 (c and f). Panels (a-c) are shown in low magnification (400×) while (d-f) in high magnification 
(1000×). HgCl2-treated livers show less compact, homogeneous distribution, more dissociated, irregular in shape and lack of delineated polygonal 
shape of hepatic parenchyma cells as compared to the controls.Ung et al. BMC Genomics 2010, 11:212
http://www.biomedcentral.com/1471-2164/11/212
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arsenic (See Additional file 3) implying that there are dif-
ferent toxicity modes between these two compounds.
Validation of targeted genes as potential biomarkers of 
mercury-induced hepatotoxicity
It is also important to identify genes whose expressions are
sensitively induced by mercury exposure. Based on strin-
gent statistical criterion (FDR<0.0005) and/or biological
function of interest, we validated selected genes using real-
time PCR. Our data indicated that 14 genes i.e. fibrinogen
alpha chain (fga), complement factor B (cfb), angiotensino-
gen  (agt), P450 oxidoreductase homolog (por homolog),
gamma-glutamyl carboxylase (ggcx), hypothetical
LOC559122 (which has predicted domain of complement
control proteins), ubiquitin conjugation enzyme E2N
(ube2n), DNA fragmentation factor (dffa), proteosome acti-
vator subunit 2 (psme2), proteosome 26S subunit (psmc3),
cytochrome c oxidase subunit VIIC (cox7c) and succinate
dehydrogenase complex subunit A (sdha)  were up-regu-
lated within 24 h of exposure to 200 μg/L of Hg(II) (Figure
6). This further confirmed biological processes such as pro-
teasome degradation (ube2n, psme2, psmc3) and apoptosis
(dffa), complement activation (cfb, hypothetical
LOC559122) and electron transport chain (por homolog,
cox7c,  sdha), acute phase response (fga,  cfb, agt) were
deregulated. However, only 7 genes i.e. por  homolog,
cox7c,  sdha  (electron transport chain), hypothetical
LOC559122, (predicted to associate with complement pro-
teins) and agt (acute phase protein), and β-c/ebp and δ-c/
ebp (for fatty liver condition, Figure 4d and 4e) were up-
regulated by 10 to 200 μg/L of HgCl2, suggesting that oxi-
dative phosphorylation, complement system, acute phase
response and lipid metabolism in the liver are highly sensi-
Figure 2 Comparison of hepatic histopathological changes in cell-cell adhesion in control liver (a, c) and induced by HgCl2 (b and d). (a) and 
(b) show immunohistochemical staining for E. cadherin (indicated by dark brown precipitates). (c) and (d) show immunohistochemical staining for 
cytokeratin (indicated by dark brown precipitates).Ung et al. BMC Genomics 2010, 11:212
http://www.biomedcentral.com/1471-2164/11/212
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Figure 3 Liver damage induced by HgCl2. (a) Quantitative histological examinations of nucleated-hepatocyte cell count based on H&E stained sec-
tions for HgCl2 treated fish was observed to significantly decrease in concentration-dependent manner (** p value < 0.05) compared to the controls. 
(b) and (c) Apoptag staining for apoptosis-induced DNA damage in hepatocytes in control (b) and HgCl.-treated zebrafish liver (c).Ung et al. BMC Genomics 2010, 11:212
http://www.biomedcentral.com/1471-2164/11/212
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tive to mercury exposure. These findings further imply the
susceptibility of the liver to oxidative stress, complement
activation, acute phase response and steatosis as a conse-
quence of mercury exposure. The environmental limit of
inorganic mercuric from the United States Environmental
Protection Agency (US EPA) in drinking water is below 2
ppb (2 μg/L) http://www.epa.gov/ogwdw000/contaminants/
dw_contamfs/mercury.html. Mercury content in human
blood is normally within the range of 0.87 to 3.51 μg/L
[34,35] and the warning level of mercury in human blood is
22.8 to 30 μg/L [34,36]. The reproducible, rapid and dose-
dependent responsiveness of these genes to a range of
HgCl2 concentrations from 10 to 200 μg/L suggested that
these genes can be potentially used as robust biomarkers in
combination with analytical chemistry detection of mercury
for investigating and assessing the severity of mercury
exposure. Furthermore, related acute phase proteins such as
angiotensinogen and complement factors that are synthe-
sized in liver and secreted into blood and excreted in urine
are potential clinical as well as toxicogenomic biomarkers
for assessing health effects of mercury exposure and war-
rants further investigation [37].
Mechanistic insights into in vivo mercury-induced 
hepatotoxicity
Taken together, our findings provide the following in vivo
mechanistic insights into mercury-induced hepatotoxicity
(Figure 7). As a strong thiol-binding agent, mercury causes
protein damage and depletion of thiol-containing antioxi-
dants (red fonts in Figure 7). Protein damage subsequently
induces proteasome pathways as well as further disruption
of cellular structure such as cell-cell adhesion and cell
motility. This may explain the very steep acute toxicity
curve (See Additional file 1) due to the rapid increase of
toxicity when protective intracellular thiol-antioxidants
have been depleted after a threshold (~200 μg/L) of HgCl2.
Transcriptome data showed deregulation of key genes in
glutathione metabolism (gstp, gstt1, pgd), providing further
evidence of disrupted thiol-antioxidants intracellular supply
(See Additional file 4).
Depletion of thiol-containing antioxidants will cause
direct (red fonts in Figure 7) and indirect (blue fonts in Fig-
ure 7) oxidative stress-mediated liver injury. Direct oxida-
tive stress induces DNA damage, mitochondrial
dysfunction such as increased oxidative phosphorylation or
electron transport chain activity and reduced activity of
fatty acid β-oxidation. These will subsequently cause
induction of mitochondria-mediated intrinsic apoptotic
pathway to release Caspase-8 to trigger apoptosis and cell
death leading to liver injury. Depletion of thiol-antioxidants
results in the overall intracellular redox balance to shift
towards increased oxidative stress, especially in the mito-
chondria where active oxidative phosphorylation occurs.
Figure 4 Fatty acid accumulation in zebrafish liver upon mercury exporure. (a-c) Oil red O staining for lipid content in control (a) and HgCl2-treat-
ed livers (b-c). Lipid content in the hepatocyte was stained and indicated by red staining showing increased of lipid content in liver of mercury-treated 
zebrafish is concentration-dependent (b-c). (e, f) Quantitative real-time PCR for mRNAs of adipogenesis genes δ-c/ebp (d), β-c/ebp (e) and apom (f). 
Results from Real-time PCR indicate level of induced gene expression in these genes are dependent to the concentration of HgCl2 and are sensitive 
to low concentration of HgCl2 at 10 μg/L. Light grey bar indicate data from microarray (** p-value < 0.05).Ung et al. BMC Genomics 2010, 11:212
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This is evident from the transcriptome analysis indicating
the deregulation of electron transport chain and mitochon-
drial fatty acid beta-oxidation in at least 3 time-points (8 h,
24 h and 48 h; Table 1), suggesting mitochondrial dysfunc-
tion occurring as early as 8 h of mercury exposure. More-
over a shift from down-regulation of extrinsic apoptosis at 8
h time-point to up-regulation of mitochondrial-mediated
intrinsic apoptosis signaling at 96 h time-point (Table 1)
strongly suggests increased mitochondrial dysfunction and
intracellular stress [38,39]. Increased apoptosis was con-
firmed through real-time PCR of up-regulated dffa (encod-
ing a substrate of Caspase 3 that triggers DNA
fragmentation during apoptosis) as showed in Figure 6 and
immunohistochemical-staining of apoptotic DNA frag-
ments in Figure 3. Some of the observed histological phe-
notypes in the liver parenchyma, such as irregular cell-
shape, loose contact with neighboring cells and signifi-
cantly reduced nucleated-cell count, may be attributed to
morphological features of apoptosis [40] as well as to mer-
cury interaction with cytoskeletal proteins [14]. E-cadherin
and Keratin-8 staining further revealed the extent of the dis-
rupted cell adhesion and cytoskeletal organization corrobo-
rating with the deregulated actin pathway and cell motility
process captured by the transcriptome data. Unmitigated
oxidative stress would cause cellular damage involving
DNA and proteins and lead to tissue injury as well as cell
lysis/death, as suggested by the up-regulation of DNA dam-
age signaling, proteasome pathway, several acute phase
protein genes (fga, agt) including complement activation.
This further explains the down-regulation of cell cycle indi-
cated in the transcriptome analysis which is necessary for
DNA repair and assessment of cellular damage, and if nec-
essary, to induce cell death instead of cell proliferation.
In addition to direct mercury-induced oxidative cellular
injury, our study has also captured indirect mercury-
induced oxidative stress-mediated gene expression/regula-
tion (blue fonts in Figure 7). Depletion of cellular thiols and
intracellular redox balance can alter activity in many tran-
scription regulators and nuclear receptors [41,42] as indi-
cated by the early deregulation nuclear receptor signaling
pathway (Table 1) that include genes such as esr1 (estrogen
receptor 1) and nr2f1l, further confirming the endocrine-
disrupting effect of mercury [43]. Our findings suggest that
the liver is a mercury-targeted organ for endocrine disrup-
tion. In addition to hormonal receptors, the up-regulation of
transcription regulators such as junb, β-c/ebp, δ-c/ebp, and
Figure 5 Glycogen accumulation in zebrafish upon mercury exposure. (a-c) Periodic acid Schiff staining (PAS) for glycogen content in control (a) 
and HgCl2-treated livers (b-c). Glycogen content in the hepatocyte was stained and indicated by pink staining. The increased of glycogen content in 
the liver of mercury-treated fish is concentration-dependent. (d and e) Quantitative real-time PCR for glycogen phosphorylase (pyg) and glycogen 
synthase kinase 3a (gsk3a) that involve in gluconeogenesis, respectively. Results from real-time PCR indicate induced gene expression in these genes 
are dependent to concentration of HgCl2. Light grey bar indicate data from microarray (* p-value < 0.1; ** p-value < 0.05).Ung et al. BMC Genomics 2010, 11:212
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keap1 suggested modulation of protective/defense and sur-
vival mechanisms involving genes associated with antioxi-
dant response element (ARE) (keap1, junb, junc, gstp1,
gclm, sqstm1) and acute phase response (β-c/ebp, δ-c/ebp,
cfb, c3, c9, fga, fgb, hpx) (See Additional file 4). Up-regu-
lated glucocorticoid receptor signaling together with β-c/
ebp could lead to gluconeogenesis and glycogen synthesis
as indicated in the transcriptome analysis and PAS staining
of glycogen as shown in Figure 5. Moreover, up-regulation
β-c/ebp and δ-c/ebp showed in Figure 4 together with the
disruption of mitochondrial fatty acid beta-oxidation could
lead to fat synthesis and accumulation. All these incidents
can eventually lead to metabolic disorders that may cause
further liver injury.
Apart from transcription regulators, it was also observed
that expression of genes encoding several kinases (cdc2,
gsk3a, mapkapk2, ptk2 and sgk) were also affected suggest-
ing that signal transduction via phosphorylation was altered
by mercury-induce oxidative stress. Modulation of kinases
involved in MAPK (Mitogen-Activated Protein Kinase)
pathways could result in up-regulation of hypoxia signaling
[44]. Furthermore, deregulated kinases such as Gsk3 will
trigger hypoxia-inducible pathways and intrinsic apoptotic
pathway. Gsk3 had been shown to activate intrinsic but not
Figure 6 Quantitative real-time PCR validation for selected genes. The expression of these selected genes were based on stringent statistical cri-
terion (FDR<0.0005) and/or biological function of interest. Most of these genes show concentration-dependent induction by HgCl2 that are also sen-
sitive to low concentration at 10 μg/L, indicating the potential of these genes as markers for mercury-induced hepatotoxicity. Light grey bar indicate 
data from microarray (* p-value < 0.1; ** p-value < 0.05).Ung et al. BMC Genomics 2010, 11:212
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extrinsic apoptotic pathway [45] and deregulate Wnt signal-
ing pathway [46,47] as indicated in the transcriptome anal-
ysis. Likewise, Wnt signaling can act as negative regulator
for adipogenesis [31,32] as its down-regulation may also
contribute to adipogenesis observed in the study.
Finally, it should be pointed out that the analysis is based
on the nominal concentration of mercury used in the expo-
sure experiment and does not reflect the amount of mercury
bioaccumulated in the tissue. Future studies should include
bioaccumulation of mercury in target tissues in order to
relate the observed effects to its actual concentration in the
tissues. This is important for assessing and comparing the
actual degree of mercury exposure in the tissue with its cor-
responding toxicological responses from different studies.
Conclusion
Our study revealed in vivo mechanistic insights of mercury-
induced hepatotoxicity that may imply complications asso-
ciated with metabolic disorders. To our knowledge, this is
the first report of an in vivo mechanistic model for mercury-
induced toxicity in the liver. Comparative analyses from
arsenic-induced hepatotoxicity in zebrafish and human
HepG2 cell line treated with HgCl2 showed some similar
effects with mercury-induced hepatotoxicity in zebrafish. In
addition, transcriptome analysis coupled with phenotypic
anchoring and targeted gene validation had revealed that
mercury can cause liver injury via broad processes associ-
ated to oxidative stress and cell death as well as deregula-
tion of kinases such as Gsk3 in regulating the activities of
Wnt signaling pathway, gluconeogenesis and adipogenesis
that may eventually lead to syndromes such as mitochon-
drial dysfunction, endocrine disruption and metabolic dis-
orders. Moreover, targeted gene validation also identified
genes whose expressions are sensitive to mercury exposure
suggesting their potential use for detecting or diagnosing
mercury-induced toxicity. Thus, the understanding of the in
Figure 7 Proposed in vivo hepatotoxicity mechanism in zebrafish upon mercury exposure. The model is proposed based on our transcriptome 
analysis, phenotype anchoring and targeted gene validation. Words in red and blue fonts are direct and indirect upstream processes induced by mer-
cury, respectively. Black words are downstream processes that are induced or suppressed by either direct or indirect effects of mercury. Please see text 
for detail description of the indicated mechanism.Ung et al. BMC Genomics 2010, 11:212
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vivo  mechanism of hepatotoxicity using zebrafish could
facilitate researches in toxicology and toxicogenomics, in
particular in vivo heavy metal toxicity. These findings pro-
vide strong evidence of the feasibility of using zebrafish to
model mercury-induced hepatotoxicity in human for risk
assessment of mercury.
Methods
The zebrafish
Adult zebrafish (6 months - 1 year old) were obtained from
a local fish farm. The fishes were allowed to acclimatize in
aquaria for several days before transferred into smaller con-
tainers for mercury exposure. For all three types of experi-
ments (i.e. microarray, histology and PCR biomarker
validation), zebrafish were exposed to mercury at different
concentrations for 96 h at a density of one fish/200 ml at 27
± 2°C. De-chlorinated water and chemical were renewed
daily. All experimental with animals were conducted fol-
lowing the guidelines of Institutional Animal Care and Use
Committee (IACUC) and the procedures were approved by
IACUC.
Mercury treatment
HgCl2  or mercury (II) chloride [99.5% A.C.S reagent;
Sigma, Aldrich] was chosen in consideration of its solubil-
ity in water that greatly facilitates daily preparation of
chemical stock. Concentrations for treatment were chosen
based on pre-LC50 and LC50 results. Concentration used
for treatment is from 0.01 - 0.2 mg/L. Prior to obtaining the
transcriptomic profiles of zebrafish, the appropriate dosage
of HgCl2 needed was determined from acute toxicity tests.
Survival analyses for zebrafish treated with various concen-
trations of HgCl2 were performed. The survival rate of sub-
lethal 200 μg/L of HgCl2 was 90% at day 7 was chosen for
subsequent microarray and toxicological studies. Treatment
for microarray analyses was carried out in 4 days, using one
concentration (200 μg/L) of HgCl2 with liver RNA sam-
pling at 8, 24, 48, and 96 hours, respectively. Treatment was
conducted using triplicate groups of four zebrafishes.
DNA Microarray Experiments
Total RNAs from triplicates (each replicate consisted of
liver pooled from four fishes) at the respective sampling
time-points were isolated by Trizol reagent from Gibco-
BRL. Reference RNA was obtained by pooling equal
amount of total RNA extracted from male and female wild-
type fish. Reference RNA was co-hybridized with RNA
samples either from treated or control fish on a glass array
spotted with 16,416 zebrafish oligo probes (16,244 LEADS
clusters and 172 copies of β-actin controls) [48]. Both ref-
erence and sample RNAs were reverse-transcribed and
labeled differently, using fluorescent dyes Cy-3 and Cy-5,
respectively. After hybridization at 42°C for 16 hours in
hybridization chambers (Gene Machines), the microarray
slides were washed in a series of washing solutions (2×
SSC with 0.1% SDS; 1× SSC with 0.1% SDS; 0.2× SSC
and 0.05× SSC; 30 seconds each), dried by low-speed cen-
trifugation and scanned for fluorescence detection using the
GenePix 4000B microarray scanner (Axon Instruments).
Further detailed protocols for microarray experiment and
data acquisition have been recently published by us [49,50].
Microarray data processing and transcriptome analysis
The raw microarray data was normalized using Lowess
method in the R package http://www.braju.com/R/. The
data had been submitted to Gene Expression Omnibus
(GEO) with accession number of GSE18861. One-way
ANOVA was performed on the normalized data followed
by Student's t-test to identified genes whose expressions are
significantly altered by HgCl2. Gene set enrichment analy-
sis (GSEA) [27] was performed to characterize pathways or
processes that are affected by HgCl2. Fishes were retreated
with HgCl2 and quantitative real-time PCR was used to val-
idate genes whose expressions were significantly altered as
well as some regulatory genes in relevant pathways affected
by HgCl2.
Analysis of Transcriptomics Profile Using Gene Set 
Enrichment Analysis (GSEA)
Gene Set Enrichment Analyses (GSEA) as described in
detail by [27] was used to determine biological pathways
perturbed by HgCl2. The zebrafish genes were mapped to
human homologous genes as previously described [22].
The human homologs of zebrafish genes from the HgCl2-
induced transcriptome profiles were ranked based on their
p-values using Student t-test. The "GSEAPreranked" option
of GSEA was used. The ranking metric used was log10 (1/
P) where P is the p-value of a gene from microarray data.
Up-regulated genes will carry positive values of log10 (1/P)
whereas down-regulated genes will carry negative values of
log10 (1/P). The genes were then ranked in descending
order based on values of log10 (1/P). The ranking proce-
dure was conducted for array at each time point of HgCl2
treatment. The ranked list of genes for each time-point
treatment will then be compared to 639 pre-defined gene
sets or signatures of canonical pathways. These pre-defined
gene sets can be downloaded from the GSEA website.
An enrichment score (ES) that reflects the degree to
which a pre-defined gene set is overrepresented at the top or
bottom rank of the ranked whole transcriptome profile was
calculated by walking down the ranked profile. The ES is
the maximum deviation from zero encountered in the ran-
dom walk corresponds to a weighted Kolmogorov-
Smirnov-like statistic. The statistical significant (nominal
p-value, NP) of the ES was estimated by using an empirical
phenotype-based permutation test procedure. The pheno-
type labels were permuted and the ES of the gene set for theUng et al. BMC Genomics 2010, 11:212
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permuted data were recomputed that generate a null distri-
bution for the ES. The empirical, nominal p-value of the
observed ES was then calculated relative to this null distri-
bution. The estimated significance level was adjusted with
multiple hypothesis testing. The ES for each gene set was
first normalized to the size of the set yielding a normalized
enrichment score (NES) with the following relation:
NES = actual ES/mean (ESs against all permutations of
the dataset)
The number of permutation used was 1000. The propor-
tion of false positive was then controlled by calculating the
false discovery rate (FDR) corresponding to each NES.
Pathways with false discovery rate (FDR) < 0.3 or nomi-
nal p-value (NP) < 0.1 were considered statistically signifi-
cant. Positive and negative values of normalized
enrichment scores (NES) indicated the activities of path-
ways that were up- and down-regulated, respectively.
Biomarker Validation with Real Time Quantitative PCR
The quantitative Real-Time PCR reaction was performed
from synthesized FirstStrand cDNA using LightCycler®
480 SYBR Green I Master kit according to the manufac-
turer's protocol (Roche). Six biological replicates were per-
formed for all real-time PCR experiments. Analysis of the
transcript levels were performed by using relative quantifi-
cation between the PCR signal of the target transcript in a
treatment group and that of an untreated control group after
normalization with the transcript level of beta-actin. The
detail information of primers used is given in Additional
file 5.
Histological Sectioning and Sample Preparation
We repeated the treatment of zebrafish with HgCl2 for his-
tological analysis. Adult zebrafish were treated with differ-
ent concentrations (50 μg/L, 200 μg/L) of HgCl2 [99.5%
A.C.S reagent; Sigma-Aldrich] for 96 hours at a density of
1 fish/200 ml at 27 ± 2°C in a static condition. Control fish
were kept in water under similar conditions, and a total of 4
fish were used for each group. Treated solution and water
were changed daily. Fish were slit open ventrally from heart
to the anus to expose the digestive organs. The whole gut
(alimentary tract including the liver) were removed and
fixed in Formalin solution 10%, Neutral Buffered (Sigma-
Aldrich) for 2-3 days at room temperature. Fixed gut sam-
ples were washed several times with 70% ethanol, followed
by dehydration in a grade series of ethanol (70% - 100%)
before clearing in Histoclear and embedding in paraffin.
The paraffin-embedded tissues were sectioned serially at 5
μm thickness. The sections were stained with hematoxylin
and eosin (H&E) for qualitative and quantitative histologi-
cal analysis.
Periodic acid-Schiff (PAS) staining
PAS staining is mainly used for staining structures contain-
ing a high proportion of carbohydrate macromolecules (gly-
cogen, glycoprotein, proteoglycans) typically found in
connective t/s, mucus and basal lamina). Staining for glyco-
gen was performed using Alcian Blue PAS stain kit without
diastase according to the manufacturer's protocol (Bio-
Genex).
Oil red O staining
Staining for adipocytes (Lipid and fat globules) was per-
formed using Cryostat Sectioning from fresh frozen liver
samples. Staining procedure was performed using Oil Red
O stain according to the manufacturer's protocol (Sigma-
Aldrich).
ApopTag staining
DNA fragmentations associated with ultrastructural
changes in cellular morphology in apoptosis were detected
using ApopTag®Plus Fluorescein In Situ Apoptosis Detec-
tion Kit according to the manufacturer's protocol (Chemi-
con). The 3'-OH ends of double-stranded or single-stranded
DNA were labeled with the digoxigenin-nucleotide and
then allowed to bind an anti-digoxigenin antibody (Anti-
DIG) that is coujugated to alkaline phosphatase. For The
DNA fragmentations localized in apoptotic bodies were
detected enzymatically using 5-Bromo-4-chloro-3-indolyl
phosphate (BCIP)/Nitroblue tetrazolium (NBT) substrate.
Histopathological examination
Histopathological analysis was performed to obtain a tis-
sue-level image of HgCl2 effects on zebrafish at 96 hours.
This also serves to further understand the gene expression
profiles resulted from the microarray analyses. Imaging of
liver sections was carried out using a compound micro-
scope, Axioskop 2, Zeiss® equipped with an imaging sys-
tem and were analyzed with a computer-assisted image
analyzer program (Axiovision, Zeiss). Liver sections from
treated fish were compared with control fish, both quantita-
tively (i.e. cell size and cell density) and qualitatively (i.e.
changes observed in liver tissue) from hematoxylin and
eosin-stained section. Density of nucleated cells (no. of
nucleated cells/5,100 μm2) and the size of nucleus were
determined with an image analyzer in both the HgCl2-
treated group and control group. Three images from each
portion (anterior, middle and posterior portions) of liver
sections (1,000× magnification) for each liver from four
control and four HgCl2-treated fish (n = 4 liver samples)
were used to determine the density of nucleated cells and to
measure the size of the nuclei for each image. A two-tailed
t-test was performed to analyze the data for statistical sig-
nificance (P < 0.05).
Images of the PAS stained sections (1,000× magnifica-
tions) were captured using Axioskop 2 for each liver fromUng et al. BMC Genomics 2010, 11:212
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four control and four HgCl2-treated fishes. Comparison of
the glycogen content in control and treated liver samples
were performed. Images of the Oil-red O stained sections
(1,000× magnifications) were also captured using Axioskop
2. Comparison of the adipocytes (lipid globules) stained
with Oil-red O from each image of control and treated liver
sections were performed.
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